Cargando…

Case Report: Severe rash/desquamation induced by sorafenib in an uHCC patient and its clinical management

Background: Sorafenib-related dermatological toxicity is a well-known adverse reaction that can severely affect therapeutic outcomes. Rash/desquamation with its variable manifestations is one of the common clinical presentations. Currently, no standard continuum of care for sorafenib-related rash/de...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yan, Liu, Ping-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514041/
https://www.ncbi.nlm.nih.gov/pubmed/36176447
http://dx.doi.org/10.3389/fphar.2022.994865